baber/WOPTO huggingface dataset:
Patent NZ-596336-A (NZ)
Title: Use of thaxtomin for selective control of rice and aquatic based weeds
Inventor: MILLAN FRANCISCO ROMERO
IPC: A01N43/38
Filed: 2010-04-15
Abstract: 596336 The use of a bacterial secondary metabolite, thaxtomin is described as an effective herbicide on broadleaved, sedge and grass weeds, e.g., in rice fieIds with no phytotoxicity to rice as well as on aquatic based weeds. The weeds controlled by the method disclosed may include: Ammania sp., Alisma plantago-aquatica, Cyperus sp., Leptochloa sp., Monochoria vaginalis, Heteranthera limosa,Sphenoclea zeylanica, Marsilea quadrifolia and Eleocharis dulcis, Scirpus mucronatus and Echinochloa colonum.
Patent NZ-596424-A (NZ)
Title: A noise attenuating and vibration dampening pedestal for an access floor assembly
Inventor: ZLATAR PETAR
IPC: E04B5/48
Filed: 2010-04-16
Abstract: 596424 Disclosed is a pedestal (10) for an access or false floor assembly (34) having noise attenuation and vibration dampening properties. The pedestal has a stand portion and a head portion. The stand portion has a base plate (12) for resting upon a sub-floor, and a rectangular metal stem (14) with four vertices extending upwardly therefrom. The head portion has a platform (16) for receiving thereon an edge region of one or more panels that define the surface of the access floor, a threaded metal shaft (18) extending downwardly therefrom, and a nut (38) which screwably engages the threaded metal shaft. The pedestal (10) includes a resilient or flexible member (40) having a ridge which engages or mates with a groove on the nut so as to lock the position of the nut on the threaded metal shaft. The resilient member has a plurality of nodules on its inner surface, at least two vertices of the metal stem being gripped between respective pairs of the nodules so as to prevent the rotation of the resilient member and the nut (38) on the metal stem (14). A resilient rubber washer is located between the resilient member and the metal stem.
Patent NZ-596834-A (NZ)
Title: Prlr-specific antibody and uses thereof
Inventor: BEDINGER DANIEL
IPC: A61K31/00
Filed: 2007-08-17
Abstract: PRLR-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating cancer.
Patent NZ-597631-A (NZ)
Title: Assisting a caller to identify that a patient is suffering from a stroke by promting a call operator to ask the caller a number of questions regarding the patient
Inventor: CLAWSON JEFFREY J
IPC: H04M11/04
Filed: 2010-07-27
Abstract: Disclosed is a computer-implemented method to assist a dispatcher when communicating with a caller via telephone (116) regarding a medical emergency of a patient (117). A dispatch center computer system (100) provides an emergency dispatch protocol (108) to assist the dispatcher (104), the protocol (108) presenting a plurality of pre-scripted interrogatories for the dispatcher (104) to ask the caller (118) to gather information regarding the emergency, and generates an emergency dispatch response by emergency responders. The dispatch center (102) computer system (100) initiates a diagnostic tool (120) on the dispatch center computer, the diagnostic tool (120) configured to assist the dispatcher (104) in guiding the caller (118) to obtain information that can be used by the diagnostic tool (120) to diagnose whether the patient (117) has suffered a stroke. The diagnostic tool (120) presents to the dispatcher (104) a user interface the provides an instruction via the user interface for the dispatcher (104) to vocally relay to the caller (118) over the telephone (116) to assist the caller (118) in identifying signs and symptoms that the patient (117) has likely suffered a stroke. The diagnostic tool (120) receives dispatcher-entered input indicative of caller relayed information concerning the caller's (118) observations of a response of the patient (117), including signs and symptoms that indicate whether the patient (117) has suffered a stroke. The caller's (118) observations are vocally relayed over the telephone (116) to the dispatcher (104) and the diagnostic tool (120) determines the likelihood that the patient (117) has suffered a stroke based on the dispatcher-entered input indicative of the caller-relayed information.
Patent NZ-598165-A (NZ)
Title: Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
Inventor: THOMPSON ANDREW M
IPC: A61K31/424
Filed: 2010-07-30
Abstract: Patent No. 598165 Disclosed is a compound having a general structure of Formula I, such as 2-Nitro-7-{ [4-(trifluoromethoxy)phenoxy]methyl} -6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine and 7-{ [4-(Benzyloxy)phenoxy]methyl} -2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine, which is useful for treating microbial infections such as tuberculosis.
Patent NZ-599889-A (NZ)
Title: Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
Inventor: KESHAVARZ-SHOKRI ALI
IPC: A61K31/443
Filed: 2008-12-04
Abstract: 599889 Disclosed is the use of an effective amount of 3-(6-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid characterized as Form I, wherein the From I is characterized by one or more peaks at 15.2 to 15.6 degrees, 16.1 to 16.5 degrees, and 14.3 to 14.7 degrees in an X-ray powder diffraction obtained using Cu K alpha radiation in the production of a medicament for treating hereditary emphysema, COPD, or dry-eye disease in a mammal.
Patent NZ-613888-A (NZ)
Title: Personalized production of biologics and method for reprogramming somatic cells
Inventor: DEISHER THERESA D
IPC: C12N5/16
Filed: 2012-01-03
Abstract: Disclosed is a method for producing a therapeutic recombinant biologic polypeptide or protein for treating a disease comprising transfecting a synthetically-produced Pluripotent Stem Cell (spPSC) with a nucleic acid that encodes for the therapeutic recombinant biologic polypeptide or protein, under conditions wherein the polypeptide or protein is expressed by the spPSC, wherein the spPSC is produced from a cell of an animal that is not within a human body. Also disclosed is the use of the therapeutic recombinant biologic polypeptide or protein for treating a disease.
Patent NZ-616048-A (NZ)
Title: Administration of iloprost as aerosol bolus
Inventor: GESSLER TOBIAS
IPC: A61P9/12
Filed: 2012-04-26
Abstract: The present disclosure relates to methods, compositions and kits useful for the treatment of pulmonary diseases such as pulmonary arterial hypertension. In particular, aerosolisable compositions of iloprost are provided which are for use in inhalation therapy. Their administration is by bolus inhalation. Bolus inhalation may, for example, be achieved using an efficient nebuliser based on the vibrating mesh technology.
Patent NZ-616817-A (NZ)
Title: Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors
Inventor: NARQUIZIAN ROBERT
IPC: C07D498/10
Filed: 2012-05-24
Abstract: The disclosure relates to spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines of formula (I) with BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of Alzheimer’s disease and type 2 diabetes. Example compounds include: (R)-N-(2’-amino-5’,5’-difluoro-2,3,5’,6’-tetrahydrospiro[indene-1,4’-[1,3]oxazine]-6-yl)-5-cyanopicolinamide, (R)-6-(5-chloropyridin-3-yl)-5’,5’-difluoro-5’,6’-dihydrospiro[chroman-4,4’-[1,3]oxazin]-2’-amine, (R)-N-(2’-amino-5’,5’-difluoro-2,3,5’,6’-tetrahydrospiro[indene-1,4’-[1,3]oxazine]-6-yl)-5-chloropicolinamide, and (R)-N-(2’-amino-5’,5’-difluoro-2,3,5’,6’-tetrahydrospiro[indene-1,4’-[1,3]oxazine]-6-yl)-5-fluoropicolinamide.
Patent NZ-619315-A (NZ)
Title: Pack for fence posts or other elongate products
Inventor: PETER KELLY
IPC: B65D85/20
Filed: 2013-12-20
Abstract: A packaging means (10) for packaging a plurality of elongate articles such as fence posts (16), stakes, pipes, steel rods or the like, comprising two opposed clamping elements (12) which are movable towards and away from each other to clamp the elongate objects (16) there between and an end cap (14) attached to the clamping elements for inhibiting axial movement of the elongate articles. The clamping elements comprise a lower clamp and an upper clamp, the clamping elements are urged together via nuts threaded onto two threaded upright elements attached to distal ends of the lower clamp. Each end cap (14) defines upper and lower panels connected via an end wall. A hole typically reinforced by a metal grommet is provided in each of the two corners of each of the upper and lower panels distal from the end panel for attaching the end cap to the clamping elements.
Patent NZ-619849-A (NZ)
Title: Antibodies that bind to ox40 and their uses
Inventor: BLEIN STANISLAS
IPC: C07K16/28
Filed: 2012-07-09
Abstract: Disclosed is an antagonist antibody or fragment thereof that binds to human OX40 comprising a heavy chain CDR1 comprising the amino acid sequence of GFSLSTSGMG, and a heavy chain CDR2 comprising the amino acid sequence of IWWDDDK, and a heavy chain CDR3 comprising the amino acid sequence of ARIDWDGFAY; and comprising a light chain CDR1 comprising the amino acid sequence of SSVSY, and a light chain CDR2 comprising the amino acid sequence of ATS and a light chain CDR3 comprising the amino acid sequence of QQWSSNPWT. Also disclosed is the use of the above-described antibody or fragment thereof in the manufacture of a medicament for treating an OX40 mediated disorder in a subject.
Patent NZ-620300-A (NZ)
Title: Method for treating schizophrenia
Inventor: UENO RYUJI
IPC: C07C69/738
Filed: 2012-08-03
Abstract: Disclosed herein is the use prostaglandin/fatty acid derivative compounds of formula I where the substituents are as defined herein, in the manufacture of medicaments for the treatment of schizophrenia.
Patent NZ-622050-A (NZ)
Title: Antibodies to cd1d
Inventor: NAMBIAR JONATHAN KANNAN
IPC: C12N15/13
Filed: 2012-10-15
Abstract: Disclosed is an isolated antibody or antigen binding portion thereof which binds to an epitope of human CD1d wherein the epitope comprises residues 87 to 93 and 141 to 143 of SEQ ID NO: 116 (sequences as defined in the specification).
Patent NZ-624382-A (NZ)
Title: Treatment of myocardial infarction using tgf - beta antagonists
Inventor: AKITA GEOFFREY Y
IPC: C07K16/28
Filed: 2011-09-01
Abstract: Disclosed is the use of an antisense or interfering RNA (RNAi) which is an antagonist of TGF-beta in the manufacture of a medicament for reducing an adverse consequence of a myocardial infarction in a patient during an acute stage of the myocardial infarction.
Patent NZ-717612-A (NZ)
Title: Switchable cas9 nucleases and uses thereof
Inventor: LIU DAVID
IPC: C12N15/113
Filed: 2014-09-05
Abstract: Some aspects of this disclosure provide compositions, methods, systems, and kits for controlling the activity and/or improving the specificity of RNA-programmable endonucleases, such as Cas9. For example, provided are guide RNAs (gRNAs) that are engineered to exist in an “on” or “off state, which control the binding and hence cleavage activity of RNA-programmable endonucleases. Some aspects of this disclosure provide mRNA- sensing gRNAs that modulate the activity of RNA-programmable endonucleases based on the presence or absence of a target mRNA. Some aspects of this disclosure provide gRNAs that modulate the activity of an RNA-programmable endonuclease based on the presence or absence of an extended DNA (xDNA).
Patent NZ-730924-A (NZ)
Title: Dosage regimen for pegylated interferon
Inventor: KLADE CHRISTOPH
IPC: A61P19/08
Filed: 2015-11-06
Abstract: A pegylated type I interferon for use in treating a myeloproliferative disease, such as polycythemia vera, in a subject in need thereof, wherein a 50 to 540 μg dose of the pegylated type I interferon is administered to the subject at a regular interval for a treatment period, the interval being 3 to 4 weeks.
Patent NZ-741423-A (NZ)
Title: Bio-based n-acetyl-l-methionine and use thereof
Inventor: JEON JIN WOO
IPC: C12P13/12
Filed: 2016-10-14
Abstract: The present disclosure relates to bio-based N-acetyl-L-methionine and a preparation method thereof. Additionally, the present disclosure relates to a feed additive containing the N-acetyl-L-methionine, a feed composition containing the feed additive, and a method for raising animals which includes feeding a feed additive containing the N-acetyl-L-methionine or a feed composition containing the feed additive to animals.
Patent NZ-741500-A (NZ)
Title: Temperature-control device for a battery system
Inventor: KREISEL PHILLIP
IPC: H01M10/617
Filed: 2016-10-18
Abstract: The invention relates to a temperature-control device (1) for a battery system, at least comprising a cuboid-shaped hollow body (2) having at least one connection device (3) for supplying and at least one connection device (4) for discharging a separately temperature-controlled fluid, a plurality of regularly arranged and identical openings (7) extending from a first body surface (5) to a second body surface (6), wherein a cylindrical battery cell (8) is accommodated by each opening (7), such that a fluid-tight fluid chamber is formed, characterised in that, with the connection of the cell head (11) and the cell base (12), the hollow body (2) extends over a height h from > 20 to < 100% of the total height H of the battery system.
Patent NZ-747598-A (NZ)
Title: Ceiling module
Inventor: PHILIP ADAMS
IPC: E04B9/06
Filed: 2018-10-23
Abstract: The invention provides a ceiling module (1) and method of constructing the same, the ceiling module mountable on a suspended ceiling grid structure and including a plurality of elongate blade members (2) having two opposing faces, at least a part of faces of at least two blade members being substantially mutually opposed, at least one elongate cross member (3, 4) extending at least between at least two adjacent blade members (2) such that the plurality of blade members are connected to form the ceiling module and define a plurality of voids between the blade members; at least one support member (3), releasably engageable with the suspended grid ceiling structure and associated with at least one of the blade members (2) mount the ceiling module from the suspended ceiling grid structure; and a cover attachable to any one of the blade members, cross members, or support members, the cover extending across at least two or more of the plurality of voids. The cover extending across multiple voids provides acoustical dampening and the technical advantage of being easier and quicker to install than traditional tiles which are installed between the blades.
Patent PT-115446-A (PT)
Title: Sistema de fabrico aditivo controlado em coordenadas cilíndricas
Inventor: NUNO ANDRÉ MATEUS DE MARQUES FRUTUOSO
IPC: B29C64/20
Filed: 2019-04-11
Abstract: O PRESENTE PEDIDO ENQUADRA-SE NA ÁREA TECNOLÓGICA DOS SISTEMAS DE FABRICO ADITIVO, DESCREVENDO UMA SOLUÇÃO QUE PERMITE AUMENTAR O VOLUME DE PRODUÇÃO POR UNIDADE DE TEMPO, MANTENDO A PRECISÃO SUB-MILIMÉTRICA E QUALIDADE DE ACABAMENTO, EM ESPECIAL PARA PEÇAS COM GEOMETRIA DE REVOLUÇÃO, BEM COMO PERMITE UTILIZAR DIFERENTES MATERIAIS DE FABRICO EM SIMULTÂNEO.É OBJETO DO PRESENTE PEDIDO UM SISTEMA DE FABRICO ADITIVO COMPOSTO POR UM CORPO RÍGIDO PRINCIPAL (1), UMA UNIDADE DE EXTRUSÃO CONTENDO PELO MENOS DOIS MÓDULOS RADIAIS DE EXTRUSÃO (4) INDEPENDENTES E COMPLANARES ENTRE SI, E POR UMA UNIDADE DE DEPOSIÇÃO CONTENDO UMA PLATAFORMA GIRATÓRIA DE DEPOSIÇÃO (3) CAPAZ DE EXECUTAR MOVIMENTO ANGULAR, E UMA PLATAFORMA ELEVATÓRIA (2), NA QUAL ASSENTA A PLATAFORMA GIRATÓRIA (3), CAPAZ DE EXECUTAR MOVIMENTO VERTICAL.
Patent RU-94013129-A (RU)
Inventor: FAJVISHEVSKIJ M L
IPC: A61K36/8962
Filed: 1994-04-14
Abstract: FIELD: meat and pharmaceutical industry. SUBSTANCE: method uses an extrusion procedure. Bile is mixed with prescription components and medicinal form making. Prescription components are endocrine, enzyme and/or special raw, vegetable origin products and taste additives. Medicinal form is formed in extruder. Products of vegetable origin are wheat flour or a mixture of wheat flour and maize starch taken at the ratio (3.5-1):1. EFFECT: intensified process, decreased cost.
Patent RU-94022102-A (RU)
Inventor: SIKHARULIDZE G G
IPC: H01J49/26
Filed: 1994-06-16
Abstract: FIELD: analytical chemistry; elementary analyses of liquids and gases, ion technology, etc. SUBSTANCE: plasma ion source has discharge chamber with inlet slit, with analyzed sample feeding device placed along its central axis through insulator and made in the form of capillary tube, high-voltage supply, and ion drawing and focusing system. EFFECT: improved sensitivity of liquid and gas analyses, simplified design and reduced cost of equipment.
Patent RU-94025045-A (RU)
Inventor: KHOLMJANSKIJ I A
IPC: G01D5/36
Filed: 1994-07-04
Abstract: FIELD: measurement technology; contactless data transmission from rotating to fixed equipment. SUBSTANCE: device has reference-signal generator 1 that feeds reference voltage in step to digital-to-analog converter 2 mounted n rotor and to digital-to-analog converter 3 placed on stator. Device is provided with great number of measuring channels arranged along rotor axis; each channel has rotor-mounted sensor 11 (12) connected through amplifier 13 to modulator 8; second input of modulator 8 is supplied with sawtooth voltage from digital-to-analog converter 2; output of modulator 8 is connected to light-emitting diodes which transmit light signal to photo diodes 15 placed on stator in same plane of revolution as light-emitting diodes. Signal picked off photodiodes 15 arrives at demodulator 10 whose second input is supplied with sawtooth voltage from digital-to-analog converter 3. Measured signal coming from demodulator 10 is passed through amplifier 16 and fed to recording unit 17. EFFECT: provision for multichannel transmission of information with high measurement accuracy and high reliability of transmission. 1 dwg
Patent RU-94025049-A (RU)
Title: High-voltage pulse power supply source (versions)
Inventor: ZAGULOV F JA
IPC: H03K3/53
Filed: 1994-07-04
Abstract: FIELD: pulse equipment. SUBSTANCE: invention refers to high-voltage pulse power supply sources used in electrophysical equipment. It may be used specifically in design of small- sized heavy-current pulse accelerators of charged particles. There are three versions of manufacture of power supply source: usage of combined insulation only, usage of solid dielectric only and combination of both dielectric media. High-voltage pulse power supply source includes pulse transformer put into closed case which primary winding is connected to case with one end which is input of power supply source. Secondary winding of transformer is output of power supply source and is placed coaxially to primary winding on cone surface of frame made of dielectric material. One end of secondary windings is connected to case, the other one - to high-voltage electrode lying on axis of mentioned frame. Secondary winding is submerged into liquid dielectric, the rest of space between case and high-voltage electrode is also filled with dielectric medium. Salient feature of source consists in provision of frame of secondary winding of transformer with at least one additional cone surface arranged coaxially to first one and in arrangement of adjacent cone surface with adverse gradient relative to each other. Each additional cone surface carries proper part of secondary winding. Combined insulation manufactured in the form of alternating layers of dielectric material separated by liquid dielectric is used as dielectric medium between case and high-voltage electrode. Dielectric material chosen from series - glycerine, alcohol, distilled water is used in the capacity of liquid dielectric placed inside case. There is space filled with liquid dielectric between surface of high-voltage electrode and combined insulation. Apart from it there is space filled with liquid dielectric located between inner surface of case of power supply source and combined insulation. EFFECT: increased number of turns of secondary winding and output voltage of power supply source without enhancement of its dimensions, expanded application field for small-sized power supply source. 14 cl, 6 dwg
Patent RU-94027919-A (RU)
Inventor: IVANOVSKIJ A P
IPC: B03D1/01
Filed: 1994-07-27
Abstract: FIELD: mining; floatation of copper and polymetal ores. SUBSTANCE: collecting and foaming agent contains 50-98% of bottom residue from 2-methyl-5-ethylpyridine rectification and 2-50% of the same from 2-methyl-2-vinylpyridine rectification, bottom residues chiefly consisting of non- polymerized pyridine bases. EFFECT: increased floatation activity due to enhanced collecting and foaming properties, and enlarged application possibilities.
Patent RU-94028981-A (RU)
Inventor: POLJASHOV L I
IPC: H02J15/00
Filed: 1994-08-01
Abstract: FIELD: electrical engineering. SUBSTANCE: device has capacitor bank inverted in electrical machine circuit and flywheel whose shaft is coupled with machine shaft through mechanical transmission and clutch; capacitor bank is assembled of series-parallel-connected pulse capacitors of superhigh energy capacity and is physically combined with flywheel by its mounting on flywheel peripheral surface; its leads of respective polarity are connected to slip rings, each being mounted on flywheel shaft and provided with brush gear for connecting to electrical machine power circuit. EFFECT: improved design.
Patent RU-94031166-A (RU)
Inventor: STEFEN MINTER
IPC: B01J20/32
Filed: 1992-12-23
Abstract: FIELD: examination of medical samples. SUBSTANCE: method of manipulating nucleic acid sequence includes (a) providing a solid carrier system to which a single-chain oligonucleotide is linked, the oligonucleotide being complementary to a specific sequence in target nucleic acid which is longer than the oligonucleotide sequence, (b) adding a source of said target nucleic acid to solid carrier system, (c) hybridization of target nucleic acid with oligonucleotide, and (d) manipulating on hybridized target nucleic acid. Manipulation may be, for example, copying or amplification of the target nucleic acid sequence. It is preferable to provide the carrier in a flow-type vessel thereby facilitating washing the carrier to remove impurities and leaving a "pure" target nucleic acid sample ready to be manipulated. Carrier should preferably have siloxane matrix suitable to bind oligonucleotide. EFFECT: improved efficiency of medical examinations.
Patent RU-94031576-A (RU)
Inventor: STAROSTIN A A
IPC: B60H1/00
Filed: 1994-08-29
Abstract: FIELD: transport engineering; automotive industry. SUBSTANCE: output branch pipe of plant is provided with screen made in form of set of semi-cylindrical plates. Screen is installed on output branch pipe for sliding and is furnished with deflector. EFFECT: improved heat masking of vehicle.